Loading insider details...
Beta
Latest Form 4 (May 2, 2025): Grant/Award of 11,600 MTNB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 2, 2025 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 11,600 | n/a |
| Jun 17, 2023 | Celularity Inc (CELU) | Grant/Award | 199,921 | n/a |
| Aug 18, 2022 | Celularity Inc (CELU) | Grant/Award | 250,000 | n/a |
| Jul 16, 2022 | Celularity Inc (CELU) | Grant/Award | 36,145 | n/a |
| Sep 13, 2021 | Celularity Inc (CELU) | Grant/Award | 56,053 | n/a |
| Sep 3, 2021 | Sorrento Therapeutics, Inc. (SRNE) | Exercise/Conversion | 75,000 | $296.3K |
| Aug 31, 2021 | Sorrento Therapeutics, Inc. (SRNE) | Grant/Award | 250,000 | n/a |
| Jul 21, 2021 | Celularity Inc (CELU) | Grant/Award | 384,297 | n/a |
| Jun 15, 2020 | Sorrento Therapeutics, Inc. (SRNE) | Grant/Award | 100,000 | n/a |
| Mar 5, 2020 | Sorrento Therapeutics, Inc. (SRNE) | Purchase | 40,000 | $90.9K |